慢阻肺病靶向治疗药物达必妥在华获批
稀土掘金
发表于 2024-9-27 18:05:21
155
0
0
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- 星巴克回应“考虑出售中国业务股份”传闻：致力于在华发展 正努力寻找最佳增长道路
- 默沙东注射用亚胺西瑞在华获批
- 默沙东PD-1抑制剂帕博利珠单抗第四项肺癌适应证在华获批
- 全球第四大车企CEO下课 Stellantis调整在华相关业务负责人
- 全球第四大车企CEO下课 Stellantis调整在华相关业务负责人
- 通用汽车在华欲重组 代价超50亿美元能否跟上市场步伐？
- 英伟达据悉在华加大招聘力度 聚焦自动驾驶技术研发
- 英伟达逆势在华扩张揽人才 一年研发人员增加数百人
- 苹果被传与腾讯、字节初步接洽 考虑将二者AI模型嵌入在华销售的iPhone
- 苹果据悉与腾讯、字节初步接洽 考虑将二者AI模型嵌入在华销售的iPhone
